G01N 33/56983
Viruses
Official title: {Viruses}
G01N33/56983 (Viruses) appears on 2,965 US grants and 4,427 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,965
- Published applications
- 4,427
- Assignees
- 2,139
- Inventors
- 10,002
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 5 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 6 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 6 | 0 |
| 1987 | 12 | 0 |
| 1988 | 13 | 0 |
| 1989 | 33 | 0 |
| 1990 | 20 | 0 |
| 1991 | 23 | 0 |
| 1992 | 34 | 0 |
| 1993 | 27 | 0 |
| 1994 | 23 | 0 |
| 1995 | 31 | 0 |
| 1996 | 43 | 0 |
| 1997 | 71 | 0 |
| 1998 | 98 | 0 |
| 1999 | 70 | 0 |
| 2000 | 67 | 0 |
| 2001 | 93 | 20 |
| 2002 | 56 | 84 |
| 2003 | 65 | 109 |
| 2004 | 44 | 104 |
| 2005 | 48 | 134 |
| 2006 | 49 | 119 |
| 2007 | 62 | 118 |
| 2008 | 57 | 96 |
| 2009 | 74 | 125 |
| 2010 | 62 | 167 |
| 2011 | 60 | 142 |
| 2012 | 57 | 110 |
| 2013 | 82 | 150 |
| 2014 | 101 | 173 |
| 2015 | 99 | 203 |
| 2016 | 113 | 181 |
| 2017 | 144 | 177 |
| 2018 | 147 | 163 |
| 2019 | 151 | 166 |
| 2020 | 125 | 139 |
| 2021 | 127 | 268 |
| 2022 | 102 | 314 |
| 2023 | 104 | 446 |
| 2024 | 109 | 364 |
| 2025 | 113 | 223 |
| 2026 | 117 | 132 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)6 Oct 2026US 12,754,184 B2Navigo Proteins GmbH
- HBV diagnostic, prognostic, and therapeutic methods and products6 Oct 2026US 12,754,185 B2Abbott Laboratories
- Magnetic tunnel junction based molecular spintronics device and magnetic resonance sensors6 Oct 2026US 12,755,883 B2University of the District of Columbia
- Quinine and its use to generate innate immune response29 Sep 2026US 12,746,236 B2The Trustees of the University of Pennsylvania
- Lassa virus-specific nanobodies and methods of their use29 Sep 2026US 12,747,284 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Optical inspection device, optical inspection system, and optical inspection method8 Oct 2026US 2026/0309635 A1Samsung Display Co., Ltd.
- Ace2 inhibition assay for evaluation of vaccine immunogenicity8 Oct 2026US 2026/0309709 A1Novavax, Inc.
- Method for customizing a biosensor to measure an analyte with high performance parameters by means of artificial intelligence8 Oct 2026US 2026/0309710 A1digid GmbH
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Zinc finger protein derivatives and methods therefor323US 6,140,466 AThe Scripps Research Institute · 2000
- Zinc finger protein derivatives and methods therefor315US 6,242,568 B1The Scripps Research Institute · 2001